An analysis of original research contributions toward FDA-approved drugs
- 1 October 2015
- journal article
- Published by Elsevier in Drug Discovery Today
- Vol. 20 (10) , 1182-1187
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The rise (and decline?) of biotechnologyDrug Discovery Today, 2014
- An overview of FDA-approved new molecular entities: 1827–2013Drug Discovery Today, 2014
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010Journal of Natural Products, 2012
- Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009Clinical Pharmacology & Therapeutics, 2010
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- Drug discovery: new models for industry–academic partnershipsDrug Discovery Today, 2009
- Why Academic Drug Discovery Makes SenseScience, 2006
- Drug Discovery: A Historical PerspectiveScience, 2000
- Accomplishments and challenges in integrating software for computer-aided ligand design in drug discoveryPerspectives in Drug Discovery and Design, 1995
- CCXXXVII.—Some phenolic derivatives of β-phenylethylamineJournal of the Chemical Society, Transactions, 1910